Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-09

FDA Approved: LOPERAMIDE HYDROCHLORIDE — Supplemental Application (Chain Drug Marketing Association Inc.)

View source ↗

Summary

The FDA approved a supplemental application for loperamide hydrochloride under an ANDA, authorizing changes to an existing product submitted by Chain Drug Marke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loperamide hydrochloride (LOPERAMIDE HYDROCHLORIDE)

Snippet

SUPPL AP for LOPERAMIDE HYDROCHLORIDE (LOPERAMIDE HYDROCHLORIDE)